Effect of o-2-hydroxy-3-(tert.-butylamino) propoxybenzonitrile HCl (KO 1366) on beta adrenergic receptors in the cardiovascular system.
D000433:1-Propanol / Q000494:pharmacology; D000318:Adrenergic beta-Agonists / Q000494:pharmacology; D000319:Adrenergic beta-Antagonists / Q000494:pharmacology; D000605:Amino Alcohols / Q000494:pharmacology*; D000628:Aminophylline / Q000494:pharmacology; D000818:Animals; D001145:Arrhythmias, Cardiac / Q000139:chemically induced; D001794:Blood Pressure / Q000187:drug effects; D002082:Butylamines / Q000494:pharmacology; D004285:Dogs; D004558:Electric Stimulation; D004837:Epinephrine / Q000037:antagonists & inhibitors; D006221:Halothane / Q000037:antagonists & inhibitors; D006321:Heart / Q000187:drug effects; D006339:Heart Rate / Q000187:drug effects; D006439:Hemodynamics / Q000187:drug effects*; D066298:In Vitro Techniques; D007545:Isoproterenol / Q000037:antagonists & inhibitors; D009570:Nitriles / Q000494:pharmacology; D010042:Ouabain / Q000037:antagonists & inhibitors; D011433:Propranolol / Q000494:pharmacology; D011817:Rabbits; D051381:Rats; D011941:Receptors, Adrenergic / Q000187:drug effects; D013233:Stellate Ganglion / Q000187:drug effects; D013565:Sympatholytics / Q000494:pharmacology*; D013997:Time Factors; D014655:Vascular Resistance / Q000187:drug effects
D000318:Adrenergic beta-Agonists; D000319:Adrenergic beta-Antagonists; D000605:Amino Alcohols; D002082:Butylamines; D009570:Nitriles; D011941:Receptors, Adrenergic; D013565:Sympatholytics; D000628:Aminophylline; D010042:Ouabain; D000433:1-Propanol; D011433:Propranolol; D007545:Isoproterenol; D006221:Halothane; D004837:Epinephrine